In this editorial, I would like to provide basic information on two seemingly disparate topics, and then bring them together in a unifying hypothesis that claims one is an underlying cause of the other. The two topics are first, the heterozygous state for a Wilson's disease genetic defect, and second, the occurrence of infantile and early childhood cirrhosis due to copper toxicity. I hypothesize that the latter primarily occurs in the presence of heterozygosity for Wilson's disease, and that this heterozygosity is often an important causal factor.By way of background, Wilson's disease is an inherited disorder of copper metabolism in which there is a failure in biliary excretion of excess copper [1,2]. As a result, these patients are not able to eliminate the small excess of copper that is present in most human diets. This daily accumulation leads to the liver becoming excessively loaded with copper, and it is damaged early in childhood. At some point, patients may present with clinically obvious liver disease, while in others, the liver disease may remain subclinical. As the liver is increasingly unable to store the excess copper, levels build up elsewhere, and the brain is the next most sensitive organ. These patients develop neurologic symptoms of a movement disorder type and often psychiatric symptomatology as well. Fortunately, there are now good treatments for Wilson's disease, and if these patients are diagnosed and treated early enough, recovery is usually substantial, they can live a normal or near-normal life, and have a normal or near-normal life expectancy [1][2][3][4]. The disease is rather rare, with frequencies around the world estimated at about 1 in 40,000. This case frequency estimate leads to an estimated heterozygous carrier frequency of 1%.The gene responsible for Wilson's disease has been cloned [5][6][7]. It is called ATP7B and codes for a protein which has copper-and membrane-binding specificities, and ATPase activity. This protein is responsible in some manner for helping the